| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
| 01/03/1996 | EP0689545A1 Macrocyclic amide and urea immunomodulators |
| 01/03/1996 | EP0689540A1 Carbacephalosporin compound, their preparation and use |
| 01/03/1996 | EP0689460A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
| 01/03/1996 | EP0689455A1 Therapeutic strategies for immunoinfective cluster virus infections |
| 01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 01/03/1996 | EP0689446A1 Drugs for the treatment of retrovirus infections |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0689381A1 Mucosal competitive exclusion flora |
| 01/03/1996 | EP0317622B1 Prevention and treatment of retroviral disease |
| 01/03/1996 | CN1114319A 1,9-bridged thiazolo(3,2-A)quinoline derivatives |
| 01/03/1996 | CN1030611C Method for preparing a novel stable form II diritromycin |
| 01/02/1996 | US5480997 Pyridine-substituted benzenemethanamine derivatives |
| 01/02/1996 | US5480987 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
| 01/02/1996 | US5480966 Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS |
| 01/02/1996 | US5480912 Method of treating HIV-1 with α-substituted benzenemethanamine derivatives |
| 01/02/1996 | US5480901 Method for reducing unwanted cellular adhesions |
| 01/02/1996 | US5480887 Protease inhibitors |
| 01/02/1996 | US5480880 Penem derivatives |
| 01/02/1996 | US5480879 Quinolonecarboxylic acids |
| 01/02/1996 | CA1337861C De-acyl derivatives of antibiotic a 40926 |
| 12/28/1995 | WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 12/28/1995 | WO1995035379A1 66 kDa ANTIGEN FROM BORRELIA |
| 12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
| 12/28/1995 | WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | WO1995035292A1 Antiviral agent containing benzodithiin derivative as active ingredient |
| 12/28/1995 | WO1995035286A1 New hiv protease inhibitors |
| 12/28/1995 | WO1995035113A1 USE OF FERROUS (III) OXYDE (Fe2O3) FOR THE TREATMENT OF IMMUNE DEFICIENCIES ESPECIALLY AIDS |
| 12/28/1995 | WO1995035112A2 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
| 12/28/1995 | WO1995035106A1 Hiv growth inhibitory composition |
| 12/28/1995 | WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 12/28/1995 | WO1995035102A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 12/28/1995 | WO1995028487A3 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
| 12/28/1995 | WO1995014713A3 Abundant extracellular products and methods for their production and use |
| 12/28/1995 | CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | CA2193496A1 Antiviral agent containing benzodithiin derivative as active ingredient |
| 12/28/1995 | CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 12/28/1995 | CA2193362A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 12/28/1995 | CA2193239A1 Hiv growth inhibitory composition |
| 12/28/1995 | CA2193220A1 New hiv protease inhibitors |
| 12/28/1995 | CA2192950A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 12/28/1995 | CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection |
| 12/28/1995 | CA2150888A1 Powder preparation for healing damaged skin |
| 12/27/1995 | EP0688868A1 Genetic detoxification of pertussis toxin |
| 12/27/1995 | EP0688789A1 Lipopeptid-derivatives, process for their preparation and their use |
| 12/27/1995 | EP0688784A2 3'-Modified oligonucleotide derivatives |
| 12/27/1995 | EP0688772A1 Novel quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation |
| 12/27/1995 | EP0688766A1 Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 12/27/1995 | EP0688333A1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
| 12/27/1995 | EP0688331A1 New sulfated lyso-ganglioside derivatives |
| 12/27/1995 | EP0688330A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 12/27/1995 | EP0688314A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 12/27/1995 | EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles |
| 12/27/1995 | EP0688222A1 Therapeutic compositions containing a lithium compound and silica |
| 12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
| 12/27/1995 | EP0688167A1 Ionene polymers as microbicides |
| 12/27/1995 | EP0555333B1 Artificial viral envelopes |
| 12/27/1995 | EP0402402B1 Inhibition of htlv-iii by exogenous oligonucleotides |
| 12/27/1995 | EP0379549B1 Endotoxin binding protein and uses thereof |
| 12/27/1995 | CN1114100A Living salmonella vaccine |
| 12/26/1995 | US5478841 Fluorinated quinolones, process for their preparation and pharmaceutical preparations containing same |
| 12/26/1995 | US5478826 Orally active azole derivatives |
| 12/26/1995 | US5478820 Antibiotic compounds |
| 12/26/1995 | US5478741 Antibodies to the HRPII protein of plasmodium falciparum |
| 12/26/1995 | US5478557 Probiotic for control of salmonella |
| 12/26/1995 | CA2004534C Metallo-organic compounds and uses thereof |
| 12/26/1995 | CA1337841C Antibiotic a 42867 derivative |
| 12/26/1995 | CA1337840C Amides of teicoplanin compounds |
| 12/26/1995 | CA1337838C Aglycons of a/16686 antibiotics |
| 12/26/1995 | CA1337803C Antibiotic produced by fermentation with amycolatopsis orientalis |
| 12/26/1995 | CA1337802C Antibiotics tan-1057 |
| 12/21/1995 | WO1995034595A1 Antiviral dendrimers |
| 12/21/1995 | WO1995034568A1 Aryl, alkyl, alkenyl, and alkynylmacrolides |
| 12/21/1995 | WO1995034565A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 12/21/1995 | WO1995034563A1 Pyrazolo and pyrrolopyridines |
| 12/21/1995 | WO1995034554A1 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 12/21/1995 | WO1995034553A1 Thiopyridines for use in the control of helicobacter bacteria |
| 12/21/1995 | WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 12/21/1995 | WO1995034322A1 Method of purifying necrotoxin produced by bordetella and toxoid |
| 12/21/1995 | WO1995034312A1 Constrained peptides |
| 12/21/1995 | WO1995034289A1 Compositions for neutralization of lipopolysaccharides |
| 12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
| 12/21/1995 | CA2576396A1 Adeno-associated virus materials and methods |
| 12/21/1995 | CA2192972A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 12/21/1995 | CA2192661A1 Compositions for neutralization of lipopolysaccharides |
| 12/21/1995 | CA2192338A1 Aryl, alkyl, alkenyl, and alkynylmacrolides |
| 12/21/1995 | CA2192206A1 Thiopyridines for use in the control of helicobacter bacteria |
| 12/21/1995 | CA2192202A1 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 12/21/1995 | CA2192165A1 Process for purifying necrotoxin produced by bordetella and toxoid |
| 12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 12/21/1995 | CA2191479A1 Constrained peptides |
| 12/20/1995 | EP0687911A2 Methods for assaying endotoxin concentration |
| 12/20/1995 | EP0687676A1 Purification of a cephalosporin salt |
| 12/20/1995 | EP0687675A2 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof |
| 12/20/1995 | EP0687471A1 Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture |
| 12/20/1995 | EP0687271A1 Extraction of cell-bound protein from bordetella |